Video

Dr. Deepak Kapoor on Integrated Urology Practices

Deepak A. Kapoor, MD, president of the Large Urology Group Practice Association, discusses the greater exposure to high-quality healthcare that is provided by the integration of ancillary services into community urology practices.

Deepak A. Kapoor, MD, president of the Large Urology Group Practice Association, chairman and CEO of Integrated Medical Professionals, PLLC, discusses the greater exposure to high-quality healthcare that is provided by the integration of ancillary services into community urology practices.

Many urology practices are now offering services, such as diagnostic, that have traditionally only been offered in a hospital setting. The state of Florida, Kapoor notes, has been a test case for the success of this system, due to its unique demographics.

Florida has a significant elderly and African American population, which are both groups with a greater than average risk of developing prostate cancer, Kapoor states. Moreover, the state contains a large Hispanic population, which is a group that tends to avoid proactive healthcare services, making accessibility to care a greater concern.

Overall, Kapoor explains, the fundamental idea behind an integrated urology practice is to provide high-quality healthcare services in a location that is more accessible to the community. Kapoor adds that services provided in hospitals can often be more expensive, inconvenient, and dehumanizing. In general, integrated urology practices in Florida have resulted in increased access to healthcare, Kapoor explains, which improves outcomes.

Related Videos
Viktor Grünwald, MD, PhD
Aaron Gerds, MD
Christine M. Lovly, MD, PhD, Ingram Associate Professor of Cancer Research, associate professor, medicine (hematology/oncology), Vanderbilt-Ingram Cancer Center
Haeseong Park, MD, MPH
David L. Porter, MD
Timothy Yap, MBBS, PhD, FRCP
Leo I. Gordon, MD, Abby and John Friend Professor of Oncology Research, professor, medicine (hematology and oncology), Feinberg School of Medicine, Robert H. Lurie Cancer Center
Hetty E. Carraway, MD, MBA, staff associate professor, Department of Medicine, School of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; member, Immune Oncology Program, Case Comprehensive Cancer Center; vice chair, Strategy and Enterprise Development, Taussig Cancer Institute, Division of Hematologic Oncology and Blood Disorders, Cleveland Clinic
David A. Braun, MD, PhD, assistant professor, medicine (medical oncology), Louis Goodman and Alfred Gilman Yale Scholar, member, Center of Molecular and Cellular Oncology, Yale Cancer Center
Julia Foldi, MD, PhD